Universal Corp Reports 66% FY26 EPS Decline, Q4 Net Loss Driven by $41M Goodwill Impairment & $52M Inventory Write-downs
Summary
Universal Corp announced a 66% drop in full-year EPS and a Q4 net loss, primarily due to a large goodwill impairment and significant inventory write-downs, reflecting persistent market headwinds and oversupply in its tobacco business, with the stock already trading near its 52-week low.
Key Events
-
Significant Earnings Decline
Fiscal Year 2026 diluted EPS fell 66% to $1.30 from $3.78 in the prior year.
-
Q4 Net Loss Reported
The company reported a net loss of $43.278 million, or -$1.73 diluted EPS, for the fourth quarter, compared to a profit of $0.37 diluted EPS in Q4 2025.
-
Goodwill Impairment Charge
A non-cash goodwill impairment charge of $41.1 million was recorded, primarily related to the Universal Ingredients-Shank's operation.
-
Substantial Inventory Write-downs
$52.0 million in inventory write-downs were recognized, mainly for non-wrapper, dark air-cured tobacco, an increase of $32.2 million from the prior fiscal year.
Analysis
Universal Corporation reported a significant decline in fiscal year 2026 earnings, with diluted EPS dropping 66% year-over-year, and a net loss in the fourth quarter. These results were heavily impacted by a $41.1 million non-cash goodwill impairment charge related to its Universal Ingredients-Shank's operation and $52.0 million in inventory write-downs, primarily for certain tobacco styles facing oversupply and softer demand. The company's uncommitted tobacco inventory levels are currently outside its target range, indicating ongoing market challenges. This negative financial performance comes as the stock is trading near its 52-week low, reinforcing investor concerns.
At the time of this filing, UVV was trading at $50.44 on NYSE in the Trade & Services sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $49.95 to $67.33. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.